Literature DB >> 8354917

Capsular types of Vibrio vulnificus: an analysis of strains from clinical and environmental sources.

U Hayat1, G P Reddy, C A Bush, J A Johnson, A C Wright, J G Morris.   

Abstract

Vibrio vulnificus produces a capsular polysaccharide (CPS) that is essential for virulence. CPS from V. vulnificus clinical strain MO6-24 has been purified and the structure determined. In preliminary screening with antisera raised to MO6-24 CPS, 4 (19%) of 21 clinical isolates (including MO6-24), but none of 67 environmental V. vulnificus isolates, agglutinated with anti-MO6-24 antisera (P = .003). CPS was isolated from a subset of 12 clinical and 7 environmental isolates and analyzed by high-performance anion-exchange chromatography and one-dimensional nuclear magnetic resonance. MO6-24 and 1 other serologically positive strain had identical CPS structures; the other 2 serologically positive strains had substitutions in two of four sugar residues. Thirteen other capsular types were identified among the remaining 15 strains from which CPS was extracted.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8354917     DOI: 10.1093/infdis/168.3.758

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

1.  Evidence for the horizontal transfer of an unusual capsular polysaccharide biosynthesis locus in marine bacteria.

Authors:  Alina Nakhamchik; Caroline Wilde; Henry Chong; Dean A Rowe-Magnus
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

2.  Differential expression of Vibrio vulnificus capsular polysaccharide.

Authors:  A C Wright; J L Powell; M K Tanner; L A Ensor; A B Karpas; J G Morris; M B Sztein
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Monoclonal antibodies against Vibrio vulnificus RtxA1 elicit protective immunity through distinct mechanisms.

Authors:  Tae Hee Lee; Sun-Shin Cha; Chang-Seop Lee; Joon Haeng Rhee; Kyung Min Chung
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

4.  Identification of the Vibrio vulnificus wbpP gene and evaluation of its role in virulence.

Authors:  Na Young Park; Jeong Hyun Lee; Myung Won Kim; Hee Gon Jeong; Byung Cheol Lee; Tae Sung Kim; Sang Ho Choi
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

5.  Real-time PCR detection of Vibrio vulnificus in oysters: comparison of oligonucleotide primers and probes targeting vvhA.

Authors:  Gitika Panicker; Asim K Bej
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

6.  Pulsed-field gel electrophoresis and ribotype profiles of clinical and environmental Vibrio vulnificus isolates.

Authors:  M L Tamplin; J K Jackson; C Buchrieser; R L Murphree; K M Portier; V Gangar; L G Miller; C W Kaspar
Journal:  Appl Environ Microbiol       Date:  1996-10       Impact factor: 4.792

7.  Chitin-induced carbotype conversion in Vibrio vulnificus.

Authors:  Jana Neiman; Yunzhi Guo; Dean A Rowe-Magnus
Journal:  Infect Immun       Date:  2011-06-13       Impact factor: 3.441

8.  The type IV leader peptidase/N-methyltransferase of Vibrio vulnificus controls factors required for adherence to HEp-2 cells and virulence in iron-overloaded mice.

Authors:  R N Paranjpye; J C Lara; J C Pepe; C M Pepe; M S Strom
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Comparative genome analysis of Vibrio vulnificus, a marine pathogen.

Authors:  Chung-Yung Chen; Keh-Ming Wu; Yo-Cheng Chang; Chuan-Hsiung Chang; Hui-Chi Tsai; Tsai-Lien Liao; Yen-Ming Liu; Hsiang-Ju Chen; Arthur Bo-Ting Shen; Jian-Chiuan Li; Teh-Li Su; Chung-Ping Shao; Chung-Te Lee; Lien-I Hor; Shih-Feng Tsai
Journal:  Genome Res       Date:  2003-12       Impact factor: 9.043

10.  Characterization of Vibrio fluvialis-like strains implicated in limp lobster disease.

Authors:  B D Tall; S Fall; M R Pereira; M Ramos-Valle; S K Curtis; M H Kothary; D M T Chu; S R Monday; L Kornegay; T Donkar; D Prince; R L Thunberg; K A Shangraw; D E Hanes; F M Khambaty; K A Lampel; J W Bier; R C Bayer
Journal:  Appl Environ Microbiol       Date:  2003-12       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.